← Back to Search

Daily Move for Stress

N/A
Waitlist Available
Research Sponsored by Calm.com, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aged 18 years or older
Score of 6 or greater on the Perceived Stress Scale-4
Timeline
Screening 3 weeks
Treatment Varies
Follow Up changes in mood will be measured at baseline, week 4, and week 8 (post-intervention). the poms is a 65-item scale with six sub scales. each item is scored on a 0-4 scale, yielding a total possible score range of -24 to 177.
Awards & highlights

Study Summary

The purpose of this study is to test the feasibility (acceptability and demand) of the Daily Move in a diverse sample of US adults. Acceptability benchmarks: 214 participants recruited within three months (60% will identify as a racial/ethnic minority; 30% African American, 30% Hispanic); At least 70% of participants rate the intervention as satisfactory. Demand benchmarks: At least 70% of participants complete 75% of prescribed Daily Move sessions per week across the 8-weeks; Dropouts not to exceed >30% of participants. Aim 2 - explore the pre-post trends in change of: Stress - Perceived Stress Scale (PSS), Anxiety and Depression - Hospital Anxiety and Depression Scale (HADS), Mindfulness- Mindful Attention Awareness Scale (MAAS), and Mood- Profile of Mood States (POMS).

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~changes in mood will be measured at baseline, week 4, and week 8 (post-intervention). the poms is a 65-item scale with six sub scales. each item is scored on a 0-4 scale, yielding a total possible score range of -24 to 177.
This trial's timeline: 3 weeks for screening, Varies for treatment, and changes in mood will be measured at baseline, week 4, and week 8 (post-intervention). the poms is a 65-item scale with six sub scales. each item is scored on a 0-4 scale, yielding a total possible score range of -24 to 177. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Stress
Secondary outcome measures
Anxiety
Depression
Mindfulness
+1 more
Other outcome measures
Study Satisfaction

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Daily MoveExperimental Treatment1 Intervention
Participants (n=107) will be provided free access to and asked to register for the consumer-based mobile meditation app, Calm, on their phone. Participants will then receive an email containing one year of free access to Calm. Participants will be asked to use the Daily Move component on the Calm app for ~10 minutes per day for 8 weeks.
Group II: Usual CareActive Control1 Intervention
Participants (n=107) will be asked to continue with usual care/routine and complete survey measures at each time point. Participants will be provided with access to the intervention after their study participation.

Find a Location

Who is running the clinical trial?

Calm.com, Inc.Lead Sponsor
6 Previous Clinical Trials
1,231 Total Patients Enrolled
Jen Huberty, PhDStudy DirectorCalm.com, Inc.
1 Previous Clinical Trials
4 Total Patients Enrolled
CalmStudy DirectorCalm.com, Inc.

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Oregon
California
How old are they?
65+
18 - 65
What site did they apply to?
Calm, Inc.
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
~43 spots leftby Mar 2025